Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia
Open Access
- 1 November 1997
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 76 (9) , 1115-1118
- https://doi.org/10.1038/bjc.1997.520
Abstract
Blood samples were collected from 52 incident cases of histologically confirmed prostate cancer, an equal number of cases of benign prostatic hyperplasia (BPH) and an equal number of apparently healthy control subjects. The three groups were matched for age and town of residence in the greater Athens area. Steroid hormones, sex hormone-binding globulin, and insulin-like growth factor 1 (IGF-1) were measured in duplicate by radioimmunoassay in a specialized US centre. Statistical analyses were performed using multiple logistical regression. The results for IGF-1 in relation to prostate cancer and BPH were adjusted for demographic and anthropometric factors, as well as for the other measured hormones. There was no relation between IGF-1 and BPH, but increased values of this hormone were associated with increased risk of prostate cancer; an increment of 60 ng ml(-1) corresponded to an odds ratio of 1.91 with a 95% confidence interval of 1.00-3.73. There was also some evidence for an interaction between high levels of testosterone and IGF-1 in relation to prostate cancer. This finding suggests that, in addition to testosterone, IGF-1 may increase the risk of prostate cancer in humans.Keywords
This publication has 16 references indexed in Scilit:
- Risk of endometrial and breast cancer in patients with diabetes mellitusInternational Journal of Cancer, 1997
- Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo.Proceedings of the National Academy of Sciences, 1996
- Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3).Endocrinology, 1995
- Clinical review: 67: Approach to chemoprevention of prostate cancer.Journal of Clinical Endocrinology & Metabolism, 1995
- Review of the role of androgenic hormones in the epidemiology of benign prostatc hyperplasia and prostate cancerUrology, 1994
- Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen.Journal of Clinical Endocrinology & Metabolism, 1993
- Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients.Journal of Clinical Endocrinology & Metabolism, 1993
- Insulin-like Growth Factors in Health and DiseaseAnnals of Internal Medicine, 1992
- Insulin-Like Growth Factors (IGFs), IGF Receptors, and IGF-Binding Proteins in Primary Cultures of Prostate Epithelial Cells*Journal of Clinical Endocrinology & Metabolism, 1991
- Are Patients with Acromegaly at Increased Risk forNeoplasia¿*Journal of Clinical Endocrinology & Metabolism, 1991